Stromal-derived factor 1–induced megakaryocyte migration and platelet production is dependent on matrix metalloproteinases

WJ Lane, S Dias, K Hattori, B Heissig… - Blood, The Journal …, 2000 - ashpublications.org
Blood, The Journal of the American Society of Hematology, 2000ashpublications.org
Despite the discovery of thrombopoietin (TPO) and its contribution to megakaryocytopoiesis,
the exact mechanisms and sites of platelet production are unknown. It has been shown that
mature megakaryocytes (MKs) functionally express the stromal-derived factor 1 (SDF-1)
receptor, CXCR4. SDF-1–induced migration of mature MKs through endothelial cell layers
results in increased platelet production. Because the migration of polyploid MKs from the
bone marrow microenvironment requires remodeling of the perivascular extracellular matrix …
Abstract
Despite the discovery of thrombopoietin (TPO) and its contribution to megakaryocytopoiesis, the exact mechanisms and sites of platelet production are unknown. It has been shown that mature megakaryocytes (MKs) functionally express the stromal-derived factor 1 (SDF-1) receptor, CXCR4. SDF-1–induced migration of mature MKs through endothelial cell layers results in increased platelet production. Because the migration of polyploid MKs from the bone marrow microenvironment requires remodeling of the perivascular extracellular matrix, it was hypothesized that mature polyploid MKs may express matrix metalloproteinases (MMPs), facilitating their exit into the bone marrow extravascular space. In this report, it is demonstrated that SDF-1 induces the expression and release of gelatinase B (MMP-9) by purified mature polyploid human MKs and an adeno-CXCR4–infected megakaryocytic cell line. Neutralizing antibody to MMP-9, but not MMP-2, blocked SDF-1–induced migration of MKs through reconstituted basement membrane, suggesting that expression of MMP-9 is critical for MK migration. Incubation of mature MKs with a synthetic MMP inhibitor, 5-phenyl-1,10-phenanthrolene, resulted in the inhibition of platelet formation, suggesting that the expression of MMPs is not only critical for megakaryocyte migration but also for subsequent platelet release. Confirming these results, adeno-SDF-1 injection into normal mice resulted in increased platelet counts, a process that could be blocked by a synthetic MMP inhibitor. These results suggest mobilization of MKs involves sequential expression and activation of chemokine receptors such as CXCR4, MMP-9, followed by transendothelial migration. MMP inhibitors may have potential use in the treatment of thrombotic and myeloproliferative disorders.
ashpublications.org